Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

INTRODUCTION: The aim of this study was to validate a molecular expression signature [cell cycle progression (CCP) score] that identifies patients with a higher risk of cancer-related death after surgical resection of early stage (I-II) lung adenocarcinoma in a large patient cohort and evaluate the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Thorac Oncol
Главные авторы: Bueno, Raphael, Hughes, Elisha, Wagner, Susanne, Gutin, Alexander S., Lanchbury, Jerry S., Zheng, Yifan, Archer, Michael A., Gustafson, Corinne, Jones, Joshua T., Rushton, Kristen, Saam, Jennifer, Kim, Edward, Barberis, Massimo, Wistuba, Ignacio, Wenstrup, Richard J., Wallace, William A., Hartman, Anne-Renee, Harrison, David J.
Формат: Artigo
Язык:Inglês
Опубликовано: Lippincott Williams & Wilkins 2015
Предметы:
Original Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272230/
https://ncbi.nlm.nih.gov/pubmed/25396679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000365
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы